For cancers lacking RB1 mutations, although the canonical functions of RB might still be disrupted through abnormal CDK activity or association with viral oncoproteins, intact non-canonical functions of RB in DNA repair might foster resistance to conventional cancer therapies. Here, RB1 is linked to cancer.